Dual inhibition of BCR-ABL and JAK kinases resulted in the up-regulation of miR-1469 and 1972 in the primary CML stem and progenitor cells accompanied with a significant reduction of CDC25B protein. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.